Sources
Wall St Engine$ABT | Abbott Labs Q2'24 Earnings Highlights: 🔹 Adj EPS: $1.14 (Est. $1.10) 🟢 🔹 Revenue: $10.38B (Est. $10.37B) 🟢 Narrowed Guidance: 🔸 FY'24 Adj EPS: $4.61 - $4.71 (Prev $4.55 - $4.70) 🟢 🔸 FY'24 Organic Sales Growth: 9.5% to 10.0% 🔸 Q3 GAAP EPS: $0.85 - $0.89 🔸 Q3 Adj…
Reuters HealthAbbott Laboratories raised its annual profit forecast and beat Wall Street estimates for second-quarter earnings on Thursday, buoyed by strong sales of its cardiac and diabetes care devices. https://t.co/zWhSvHogiD https://t.co/zWhSvHogiD
BloombergAbbott Laboratories nudged up its full-year profit guidance as strong growth in its medical-devices segment helped quarterly results beat estimates https://t.co/Hlci7xV3Xt
Additional media











